Skip to main content

FDA pharmacologic class

Insulin Analog

7 medicines are in FDA's class of insulin analogs: water (Medi-First), insulin aspart (Novolog), insulin lispro (Humalog), insulin glargine (Lantus), insulin degludec (Tresiba), insulin glulisine (Apidra) and insulin detemir (Levemir); 2 combination products also contain one. 1 of the 9 are listed from generic labelers (FDA NDC Directory, October 8, 2026). The lowest pharmacy cost is water for injection vial at $0.315 per mL (NADAC).

Which medicines are insulin analog?

Recalls: FDA enforcement reports, 2012 on
MedicineBrand namesGeneric labelers (all forms)Pharmacy costBoxed warningShortageRecalls since 2012
WaterPur-Wash, Physicianscare, Medi-First11 labelers$0.315 per mL Water for injection vialNoIn shortage12
Insulin aspartNovolog, Fiasp, Kirstynone listed$6.95 per mL 100 unit/mL vialNoNo current entry5
Insulin lisproHumalog, Lyumjev, Admelognone listed$10.19 per mL 100 unit/mL kwikpenNoA presentation being discontinued4
Insulin glargineLantus, Toujeo, Semgleenone listed$2.90 per mL 100 penNoA presentation being discontinued2
Insulin degludecTresibanone listed$11.39 per mL 100 unit/mL penNoNo current entry3
Insulin glulisineApidranone listed$8.16 per mL 100 unit/mL vialNoNo current entry0
Insulin degludec and liraglutideXultophynone listed$85.89 per mL 100 unit-3.6 mg/mL penYesNo current entry1
Insulin detemirLevemirnone listedn/aNoNo current entry0
Insulin glargine and lixisenatideSoliquanone listed$57.06 per mL 100 unit-33 mcg/mL penNoNo current entry0

Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)

What do pharmacies pay?

Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.

Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price

What next?